| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021088787-A1 | Quinazoline compound used as axl inhibitor | 2019-11-07 |
| WO-2020242245-A1 | Phthalazinone compounds and use thereof | 2019-05-29 |
| CN-113840820-A | Phthalazinone compounds and uses thereof | 2019-05-29 |
| KR-20210137216-A | Phthalazinone compounds and uses thereof | 2019-05-29 |
| CN-113330001-A | 3, 3-difluoroallylamine or salt thereof and pharmaceutical composition containing same | 2018-12-14 |
| WO-2019173761-A1 | C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same | 2018-03-09 |
| US-2021101872-A1 | C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same | 2018-03-09 |
| JP-2020505437-A | Small molecule inhibitors of neutral sphingomyelinase 2 (nSMase2) for the treatment of neurodegenerative diseases | 2017-01-06 |
| KR-20190110106-A | Small molecule inhibitors of neutral sphingomyelinase 2 (nSMAse2) for the treatment of neurodegenerative diseases | 2017-01-06 |
| US-2020190089-A1 | Small molecule inhibitors of neutral sphingomyelinase 2 (nsmase2) for the treatment of neurodegenerative diseases | 2017-01-06 |
